EMEA-000463-PIP02-10 - paediatric investigation plan

imatinib mesilate
PIPHuman

Key facts

Invented name
Glivec
Active Substance
imatinib mesilate
Therapeutic area
Cardiovascular diseases
Decision number
P/85/2011
PIP number
EMEA-000463-PIP02-10
Pharmaceutical form(s)
  • Film-coated tablet
  • Capsule, hard
  • Age appropriate oral solid dosage form
Condition(s) / indication(s)
Treatment of pulmonary arterial hypertension
Route(s) of administration
Oral use
Contact for public enquiries

Novartis Europharm Limited
E-mail: paediatric.enquiries@novartis.com
Tel. +41 613241111

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Decision date

Decision

Share this page